ZA957649B - Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin - Google Patents

Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin

Info

Publication number
ZA957649B
ZA957649B ZA957649A ZA957649A ZA957649B ZA 957649 B ZA957649 B ZA 957649B ZA 957649 A ZA957649 A ZA 957649A ZA 957649 A ZA957649 A ZA 957649A ZA 957649 B ZA957649 B ZA 957649B
Authority
ZA
South Africa
Prior art keywords
pallidipin
manufacture
platelet aggregation
aggregation inhibitor
induced platelet
Prior art date
Application number
ZA957649A
Other languages
English (en)
Inventor
Christiane Dr Noeske-Jungblut
Andreas Dr Becker
Bernard Dr Haendler
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA957649B publication Critical patent/ZA957649B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA957649A 1994-09-12 1995-09-12 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin ZA957649B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94250224 1994-09-12

Publications (1)

Publication Number Publication Date
ZA957649B true ZA957649B (en) 1996-04-15

Family

ID=8217517

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957649A ZA957649B (en) 1994-09-12 1995-09-12 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin

Country Status (22)

Country Link
US (1) US5882887A (fr)
EP (1) EP0781334A1 (fr)
JP (1) JPH10505502A (fr)
CN (1) CN1075836C (fr)
AU (1) AU701643B2 (fr)
BG (1) BG63276B1 (fr)
BR (1) BR9508910A (fr)
CA (1) CA2199719A1 (fr)
CZ (1) CZ76297A3 (fr)
FI (1) FI971013A0 (fr)
HU (1) HU222398B1 (fr)
IL (1) IL115272A0 (fr)
MX (1) MX9701720A (fr)
NO (1) NO971110L (fr)
NZ (1) NZ293261A (fr)
PL (1) PL184617B1 (fr)
RO (1) RO117971B1 (fr)
RU (1) RU2186110C2 (fr)
SI (1) SI9520093A (fr)
SK (1) SK29297A3 (fr)
WO (1) WO1996008563A1 (fr)
ZA (1) ZA957649B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01009363A (es) * 1999-03-18 2002-06-04 Merck Patent Gmbh Proteina para bloquear la adhesion de plaquetas.
EP1831395A1 (fr) * 2004-12-28 2007-09-12 Ares Trading S.A. Compositions et procedes de traitement de la schizophrenie et de troubles associes
CA2623565A1 (fr) * 2005-09-28 2007-04-05 Biovascular, Inc. Methodes et compositions servant a bloquer l'adherence plaquettaire et cellulaire, la migration cellulaire et l'inflammation
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
TWI391143B (zh) * 2005-11-04 2013-04-01 Otsuka Pharma Co Ltd 血小板凝集抑制劑組成物
US9617302B2 (en) * 2011-06-14 2017-04-11 National Taiwan University Peptide compounds for inhibition of platelet aggregation
FR2979346B1 (fr) 2011-08-23 2013-09-27 Univ Joseph Fourier Nanocorps anti-vcam-1
JP6188728B2 (ja) 2012-02-07 2017-08-30 グローバル・バイオ・セラピューティクス・インコーポレイテッドＧｌｏｂａｌ Ｂｉｏ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 核酸送達の区画化方法ならびにその組成物および使用
AU2013311606B2 (en) 2012-09-07 2017-10-05 Inserm (Institut National De La Sante Et De La Recherche Medicale) Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) Trem-Like Transcript 1 (TLT-1) and uses thereof
HK1225258B (en) 2013-08-08 2017-09-08 Global Bio Therapeutics, Inc. Clamping device for minimally invasive surgery
FR3058143B1 (fr) 2016-10-27 2021-03-12 Univ Grenoble Alpes Nanocorps anti-tau
US20240366681A1 (en) 2021-08-13 2024-11-07 Triovance Holding Llc A skin substitute composition and methods of producing and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0371041A1 (fr) * 1987-06-24 1990-06-06 Novo Nordisk A/S Procede de preparation d'une proteine ou d'un polypeptide, sequence d'adn codant pour le polypeptide, microorganisme contenant la sequence d'adn et le polypeptide et utilisation du polypeptide comme preparation pharmaceutique
WO1993005150A1 (fr) * 1991-09-05 1993-03-18 Schering Aktiengesellschaft Inhibiteur de l'agregation plaquettaire provoquee par collagene
US5756454A (en) * 1991-09-05 1998-05-26 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences

Also Published As

Publication number Publication date
NO971110L (no) 1997-05-07
US5882887A (en) 1999-03-16
MX9701720A (es) 1997-06-28
BG101226A (bg) 1998-10-30
IL115272A0 (en) 1995-12-31
BR9508910A (pt) 1997-10-28
RO117971B1 (ro) 2002-11-29
CZ76297A3 (cs) 1998-01-14
EP0781334A1 (fr) 1997-07-02
BG63276B1 (bg) 2001-08-31
FI971013A7 (fi) 1997-03-11
WO1996008563A1 (fr) 1996-03-21
SI9520093A (en) 1997-08-31
HUT76972A (hu) 1998-01-28
HU222398B1 (hu) 2003-06-28
NO971110D0 (no) 1997-03-11
NZ293261A (en) 1998-11-25
JPH10505502A (ja) 1998-06-02
CA2199719A1 (fr) 1996-03-21
PL319078A1 (en) 1997-07-21
AU3565795A (en) 1996-03-29
SK29297A3 (en) 1997-10-08
AU701643B2 (en) 1999-02-04
CN1075836C (zh) 2001-12-05
RU2186110C2 (ru) 2002-07-27
PL184617B1 (pl) 2002-11-29
CN1159828A (zh) 1997-09-17
FI971013A0 (fi) 1997-03-11

Similar Documents

Publication Publication Date Title
GB9423332D0 (en) Method of making a library of compounds
IL122814A0 (en) Inhibitors of platelet aggregation
ZA957649B (en) Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
EP0715908A3 (fr) Procédé pour fabriquer un article en forme de gobelet
GR3030456T3 (en) Process for the manufacture of n-phosphonomethylglycine
GR3031206T3 (en) Production of a siliceous refractory mass
EP0707034A3 (fr) Procédé de fabrication de matériau expansé
ZA954204B (en) A process for improving the effectiveness of a process catalyst
SG47817A1 (en) Organsulfur compounds a process for their production and their use
AU681215B2 (en) A process for the purification of fullerenes
IL112707A0 (en) Process for the manufacture of a ceramic part
GB9622712D0 (en) Process for the manufacture of a packaging blank
GB2296722B (en) Method of producing a flexible absorbent article
GB2286152B (en) A method of discriminating an article
SG50583A1 (en) Process for manufacture of a zeolite
IL115848A0 (en) Production of triazoles
GB9821822D0 (en) Process for the manufacture of a product
GB9406432D0 (en) Process for the manufacture of a zeolite
IL108824A0 (en) A process for the acylation of ferrocene
IL117651A0 (en) Process for the manufacture of a polyolefin shaped article
HUT51628A (en) A new process for producing macrolidous compounds having antibiotical effect
KR0108496Y1 (en) Evaporator of a cooling machine
ZA965905B (en) New inhibitors of platelet aggregation
IL110424A0 (en) A process for purification of used oils
GB9408523D0 (en) Process for the racemisation of a chiral compound